Tango Therapeutics TNGX Quick ratio
Quick ratio at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's quick ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's quick ratio?
- Tango Therapeutics (TNGX) reported quick ratio of 27.4× in Q1 2026.
- How has Tango Therapeutics's quick ratio changed year-over-year?
- Tango Therapeutics's quick ratio increased by 337.2% year-over-year, from 6.3× to 27.4×.
- What is the long-term trend for Tango Therapeutics's quick ratio?
- Over 5 years (2020 to 2025), Tango Therapeutics's quick ratio has grown at a 28.1% compound annual growth rate (CAGR), from 4.7× to 16.3×.
- What does quick ratio mean?
- Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.